Agreement of concomitant cardiac output measurement by thoracic bio‐impedance and inert gas rebreathing in healthy subjects

Purpose Inasmuch as they are deemed valid, noninvasive measurement of cardiac output techniques present advantages of ease and safety for use in humans. Few studies have compared the use of thoracic bioimpedance and inert gas rebreathing techniques for cardiac output (CO) assessment at rest and exer...

Full description

Saved in:
Bibliographic Details
Published inClinical physiology and functional imaging Vol. 45; no. 3; pp. e70005 - n/a
Main Authors Filaire, Laura, Perrault, Hélène, Dauphin, Claire, Chalard, Aurélie, Pereira, Bruno, Costes, Frederic, Richard, Ruddy
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.05.2025
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN1475-0961
1475-097X
1475-097X
DOI10.1111/cpf.70005

Cover

Loading…
More Information
Summary:Purpose Inasmuch as they are deemed valid, noninvasive measurement of cardiac output techniques present advantages of ease and safety for use in humans. Few studies have compared the use of thoracic bioimpedance and inert gas rebreathing techniques for cardiac output (CO) assessment at rest and exercise. This manuscript reports on differences between Physioflow® and Innocor® CO measurements at rest and during cycling in a population of healthy subjects. Methods Fifty healthy subjects (52 ± 16 years) underwent an incremental cycle exercise testing (IET) during which standardized Physioflow® and Innocor® CO assessments were achieved. Measurements were completed in a subgroup of twelve subjects during two constant‐load 10‐min cycling bouts at moderate and high intensities. Results Mean difference between Physioflow® and Innocor® was of 0.002 ± 0.98 l/min at rest and 0.38 ± 1.31 l/min during IET without statistical difference. Correlation coefficient values were higher for exercise (r = 0.83) than resting (r = 0.40) measurements. Good reproducibility of the two devices was observed on different graded exercises with intraindividual variability lower than 6%, except for rest Innocor® CO measurements (CV = 18%). Conclusion Physioflow® and Innocor® can be easily used concomitantly for noninvasive measurement of CO. Despite finding a strong agreement between techniques for exercise CO, results should not be interpreted as being interchangeable as values are derived from different flow measurements: systemic blood flow for Physioflow® and pulmonary blood flow for Innocor®. However, the concomitant use of both techniques could be of value in clinical setting for noninvasive intrathoracic shunt quantification.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1475-0961
1475-097X
1475-097X
DOI:10.1111/cpf.70005